Edition:
United States

Zhejiang Medicine Co Ltd (600216.SS)

600216.SS on Shanghai Stock Exchange

9.64CNY
18 Sep 2018
Change (% chg)

¥0.53 (+5.82%)
Prev Close
¥9.11
Open
¥9.18
Day's High
¥9.74
Day's Low
¥9.15
Volume
39,902,096
Avg. Vol
19,608,752
52-wk High
¥18.05
52-wk Low
¥9.07

Latest Key Developments (Source: Significant Developments)

Zhejiang Medicine 's 2017 Preliminary Net Profit Down, But Sees Q1 Net Profit Surging
Monday, 12 Mar 2018 06:26am EDT 

March 12 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS ITS PRELIMINARY 2017 NET PROFIT DOWN 41.52 PERCENT Y/Y AT 263.2 MILLION YUAN ($41.62 million).SAYS IT SEES Q1 NET PROFIT UP 1,815.81-2,190.65 PERCENT Y/Y AT 435.99-525.99 MILLION YUAN.  Full Article

Zhejiang Medicine passes review of high-tech enterprise recognition
Thursday, 21 Dec 2017 10:28pm EST 

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years.  Full Article

Zhejiang Medicine terminates clinical trial for a kind of antitumor drug
Thursday, 21 Dec 2017 10:25pm EST 

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it decided to terminate clinical trials for a kind of antitumor drug (R&D code name of XC302).  Full Article

Zhejiang Medicine's 9-month net profit down 67.55 pct y/y
Sunday, 22 Oct 2017 07:55am EDT 

Oct 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>:Says its 9-month net profit down 67.55 percent y/y from 405 million yuan ($61.19 million) a year ago.  Full Article

Zhejiang Medicine says change of accounting policy
Tuesday, 29 Aug 2017 09:59am EDT 

Aug 29(Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::* Says it changed the accounting policy due to national policy requirement.  Full Article

Zhejiang Medicine's unit to bring in strategic investor with Future Industry Investment Fund
Monday, 7 Aug 2017 07:10am EDT 

Aug 7 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>:Says board approves unit to bring in strategic investor with Future Industry Investment Fund investing 600 million yuan ($89.30 million) for 37.9 percent stake.  Full Article

Zhejiang Medicine unit receives Canada GMP certificate
Friday, 21 Jul 2017 07:12am EDT 

July 21(Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::* Says its unit receives Canada GMP certificate for vancomycin hydrochloride and related APIs.  Full Article

Zhejiang Medicine to pay FY 2016 annual div on July 19
Wednesday, 12 Jul 2017 03:50am EDT 

July 12(Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::* Says it will pay FY 2016 dividend to shareholders of record on July 18.* The company's shares will be traded ex-right and ex-dividend on July 19 and the dividend will be paid on July 19.  Full Article

Zhejiang Medicine to pay annual cash div as 1.45 yuan per 10 shares for FY 2016
Wednesday, 12 Apr 2017 04:48am EDT 

Zhejiang Medicine Co Ltd <600216.SS> :Says it plans to pay annual cash dividend as 1.45 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Kaneka wins lawsuit regarding patent infringement in US
Thursday, 26 Jan 2017 04:56am EST 

Kaneka Corp <4118.T>: Says the co won the lawsuit against Zhejiang Medicine Co. Ltd <600216.SS> and ZMC-USA, LLC. .Says the lawsuit regarding patent infringement of oxidized coenzyme Q10(KanekaQ10™) in the U.S..  Full Article

BRIEF-Zhejiang Medicine's 2017 Net Profit Down, Q1 Net Profit Up

* SAYS 2017 NET PROFIT DOWN 43.8 PERCENT Y/Y AT 253.1 MILLION YUAN ($40.13 million)